| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
3,044 |
2,735 |
$244K |
| 80050 |
General health panel |
2,350 |
2,341 |
$74K |
| 80061 |
Lipid panel |
2,545 |
2,531 |
$30K |
| 80053 |
Comprehensive metabolic panel |
1,576 |
1,545 |
$15K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,585 |
1,573 |
$14K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,789 |
1,741 |
$13K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
200 |
196 |
$11K |
| 84439 |
|
1,237 |
1,235 |
$10K |
| 81001 |
|
1,394 |
1,370 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
106 |
106 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
60 |
58 |
$882.98 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
32 |
31 |
$868.48 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
16 |
15 |
$723.68 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
14 |
14 |
$436.94 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
45 |
44 |
$334.02 |
| 84153 |
|
14 |
14 |
$229.04 |
| 84481 |
|
15 |
15 |
$226.05 |
| 81003 |
|
91 |
91 |
$182.07 |
| 82043 |
|
36 |
35 |
$181.63 |
| 82570 |
|
36 |
35 |
$160.63 |
| 85018 |
|
12 |
12 |
$26.76 |